✦ LIBER ✦

Mortality and morbidity of patients with neuroblastoma who survived for more than 10 years after treatment—Niigata Tumor Board Study

✍ Scribed by Masayuki Kubota; Naoki Okuyama; Yutaka Hirayama; Keiko Asami; Atsushi Ogawa; Akihiro Watanabe

Book ID: 116688090
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 201 KB
Volume: 45
Category: Article
ISSN: 0022-3468
DOI: 10.1016/j.jpedsurg.2009.09.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors in patients who survi

Prognostic factors in patients who survived more than 10 years after undergoing surgery for metastatic brain tumors: Report of 5 cases and review of the literature

✍ Hideo Takeshima; Jun-ichi Kuratsu; Toru Nishi; Yukitaka Ushio 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Evaluation of patients with advanced neu

Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: A report from the study group of Japan for treatment of advanced neuroblastoma

✍ Iwafuchi, Makoto; Utsumi, Jiro; Tsuchida, Yoshiaki; Kaneko, Michio; Matsuyama, S 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

In January 1985, a single protocol consisting of cyclophosphamide, vincristine, tetrahydropyranyl adriamycin, and cis-platinum for the treatment of advanced neuroblastoma was begun nationwide in Japan and was found to improve clinical results significantly in terms of 2-or 3year survival rate. Betw